Evoke Pharma, Inc. (EVOK)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.58 |
| Open | 5.43 |
| Bid | 3.80 x 200 |
| Ask | 6.65 x 200 |
| Day's range | 5.08 - 5.57 |
| 52-week range | 3.54 - 17.88 |
| Volume | |
| Avg. volume | 72,759 |
| Market cap | 4.236M |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Evoke Pharma Second Quarter 2024 Earnings: Misses Expectations
Evoke Pharma ( NASDAQ:EVOK ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.55m (up 125% from 2Q...
- Simply Wall St.
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
We feel now is a pretty good time to analyse Evoke Pharma, Inc.'s ( NASDAQ:EVOK ) business as it appears the company...
- Insider Monkey
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
© 2024 Yahoo. All rights reserved.